Organization | Jackson Laboratory

Jackson Laboratory Report issue

For profit Phase 4

Founded: Bar Harbor ME United States (1929)

Organization Overview

First Clinical Trial

2017

NCT03104075

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

The Jackson Laboratory | The Jackson Laboratory for Genomic Medicine

Active Ingredients

Drugs in Phase 4 Trials (2)

inactivated influenza vaccine (1 trial)

vancomycin (Vancocin) (1 trial)

Drugs in Other Trials (3)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

walnut (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Clostridium Infections (Phase 4)

Hematologic Diseases (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 5
# of Trial APIs: 5